Genetic variation in CNNM2 reduces serum magnesium and increases deficiency risk.

Clinical evidence

• Genome-Wide Association Studies (GWAS): Large-scale genetic studies have consistently identified the CNNM2 locus as a primary genetic determinant of serum magnesium levels in the general population. Common single nucleotide polymorphisms (SNPs) at this locus are significantly associated with variations in circulating magnesium concentrations ($p < 5 \times 10^{-8}$).
• Pathogenic Mutations and Hypomagnesemia: While common variants cause subtle, subclinical shifts in magnesium levels, rare loss-of-function mutations in CNNM2 result in severe, autosomal dominant renal hypomagnesemia type 6. Patients with these mutations present with profoundly low serum magnesium levels (often $< 0.5 \text{ mmol/L}$, compared to a normal range of $0.75 - 0.95 \text{ mmol/L}$), leading to muscle cramps, fatigue, and neurological symptoms.

Mechanistic explanations

• Renal Magnesium Handling: The CNNM2 (cyclin and CBS domain-containing divalent metal cation transport mediator 2) gene encodes a basolateral membrane protein highly expressed in the distal convoluted tubule (DCT) of the kidney. The DCT is the final site of regulated magnesium reabsorption, determining the final amount of magnesium excreted in the urine.
• Impaired Reabsorption Pathway: CNNM2 is hypothesized to act as a basolateral magnesium sensor or exporter that drives transcellular magnesium reabsorption. Genetic variations and mutations disrupt CNNM2 localization, trafficking, or interaction with other transport regulators (such as TRPM6). This disruption impairs basolateral magnesium efflux from the DCT cells into the interstitial space, leading to a failure in renal reabsorption and consequent renal magnesium wasting.

Bottom line

Genetic variation in CNNM2 is a scientifically validated cause of lower serum magnesium levels. This variation directly compromises renal tubular magnesium reabsorption, leading to increased urinary excretion and elevating the susceptibility to clinical magnesium deficiency and its associated neuromuscular complications.